Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

CytomX Therapeutics (CTMX) has drawn fresh interest ahead of its presentation at the SITC annual meeting. The company will share early data from its Phase 1 study of CX-801 in advanced melanoma ...

University faculty provides insight on AI research programs, including the RISE initiative and iTREDS program, while also ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

St. Croix Foundation for Community Development is pleased to announce the upcoming release of the territory’s annual ...

What is the AMSS system? Hundreds of flights were delayed at Delhi's Indira Gandhi International Airport on Friday morning. A ...

Despite months of community pushback, construction appears to have started on a controversial AI data center in a rural part ...

Louis Navellier Dollar Upgrade Review reveals how his Growth Investor service and Stock Grader help you profit from America’s ...

Health care occupations, as well as data science and tech related jobs, are expected to see among the fastest growth in ...

Deutsche Telekom is making a major push into artificial intelligence (AI) infrastructure, teaming up with US chipmaker Nvidia ...

Las Vegas Event Seeks Industry Leaders To Share Supply Chain Innovations and Best Practices Using GS1 Standards ...